Explain why Tresiba's (insulin degludec) longer duration isn't always better

January 2016

Tresiba (treh-SEE-bah, insulin degludec) is a new once-daily ULTRA long-acting insulin.

It lasts about 42 hours...compared to about 24 hours for Lantus or Levemir and a little over 24 hours for Toujeo.

You may hear that Tresiba's longer duration means it doesn't need to be used at the same time every day.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote